The evaluation of acquired aplastic anemia in children and unexpected frequency of varicella-zoster virus association: A single-center study

Turkish Journal of Pediatrics

Volumn 50, Issue 4, 2008, Pages 342-348

  Yetgin, Sevgi ^a   Kuşkonmaz, Bariş ^a   Aytaç, Selin ^a   Çetin, Mualla ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acquired aplastic anemia; Children; Varicella zoster virus

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; CHLORPHENOTANE; COLCHICINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPYRONE; IBUPROFEN; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; OXYMETHOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; MALE; PARVOVIRUS INFECTION; PATIENT COMPLIANCE; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; SUICIDE ATTEMPT; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VARICELLA ZOSTER VIRUS; CAUSE OF DEATH; DRUG COMBINATION; EVALUATION; HOSPITALIZATION; INFANT; MORTALITY; PATHOGENICITY; VIRUS HEPATITIS;

ADOLESCENT; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEPATITIS, VIRAL, HUMAN; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; METHYLPREDNISOLONE; SEVERITY OF ILLNESS INDEX;

EID: 58149203509     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Heimel H. Epidemiology and etiology of aplastic anemia. In: Shrenmeier H, Bacigalupo Asditus (eds). Aplastic Anemia Pathophysiology and Treatment. New York: Cambridge University Press; 2000: 97-116.
2. Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1990; 75: 1646-1653.
3. Young NS, Alter BP. Epidemiology of acquired aplastic anemia. In: Young NS, Alter BP (eds). Aplastic Anemia Acquired and Inherited. Philadelphia: WB Saunders; 1994: 24-31.
4. Brown KE, Tisdale J, Barrett AJ. Hepatitis-associated aplastic anemia. N Engl J Med 1997; 336: 1059-1064.
5. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med 1997; 48: 59-67.
6. Yetgin S, Cetin M, Ozyurek E, et al. Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient. Pediatr Hematol Oncol 2004; 21: 223-226.
7. Kaptan K, Beyan C, Ural AU, et al. Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT. Am J Hematol 2001; 67: 252-255.
8. Kook H, Kim GM, Kim HJ, et al. Rubella-associated aplastic anemia treated by syngeneic stem cell transplantations. Am J Hematol 2000; 64: 303-305.
9. Bader-Meunier B, Dusser A, Mersh JM, et al. Varicella-associated pancytopenia. Eur J Pediatr 1990; 149: 810-811.
10. Kaufman DW, Kelly JP, Jurgelon JM, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 1996; 60: 23-30.
11. Yetgin S, Ozyurek E, Aslan D, et al. Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy. Pediatr Hematol Oncol 2004; 21: 343-347.
12. Gluckman E, Devergie A, Poros A, et al. Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol 1982; 51: 541-550.
13. Doney K, Pepe M, Storb R, et al. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 1992; 79: 2566-2571.
14. Bacigalupo A. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group. Eur J Haematol Suppl 1996; 60: 16-19.
15. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Bloo Blood 2000; 96: 2049-2054.
16. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 2000; 95: 1931-1934.
17. Ozsoylu S. High dose intravenous methylprednisolone (HDIMP) in hematologic disorders. Hematol Rev 1990; 4: 197-207.
18. Tzakis AG, Arditi M, Whitington PF, et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988; 319: 393-396.
19. Munakata Y, Saito-Ito T, Kumura-Ishii K. Ku80 auto-antigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005; 106: 3349-3356.
20. Lee JH, Lee JH, Shin YR, et al. Spontaneous remission of aplastic anemia: a retrospective analysis. Haematologica 2001; 86: 928-933.
21. Fuhrer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 2005; 106: 2102-2104.